Record profits at Glaxo

This was on the internet this morning:Updated 11:37 AM ET February 21, 2001 LONDON (AP) - Strong sales for its respiratory, antiviral and central-nervous-system drugs helped boost GlaxoSmithKline PLC profits by 13 percent last year, the company announced Wednesday. Pretax profit for the year ending Dec. 31 was 5.33 billion pounds ($7.73 billion), or 61 pence per share (88 cents), up from 4.71 billion pounds, or 52.7 pence per share, in 1999. The year-end results are pro forma, reflecting the combined results of Glaxo Wellcome PLC and SmithKline Beecham PLC, whose long-delayed merger was completed Dec. 27. Looks like, whatever hit they may have taken with Lotronex didn't hurt the bottom line that much. Now maybe they can find it in their hearts to make Lotronex available to us poor IBS - D sufferers!echris